Clinical Trial Update: Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating mosunetuzumab in combination with chemotherapy for untreated C-MYC rearrangement-positive high-grade B-cell lymphoma or di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma

Drugs mentioned

• Mosunetuzumab (mosunetuzumab)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Diffuse Large B-Cell Lymphoma, High Grade B-Cell Lymphoma | Phase 1, Phase 2 | Status: RECRUITING